U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07565779) titled 'Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels' on April 27.
Brief Summary: Individuals with ESKD and treated with hemodialysis have a high mortality risk. Associative studies suggest a relationship between serum magnesium concentration and mortality risk. The influence of magnesium concentration on mortality risk is unknown. This pilot study will explore whether altering dialysate magnesium concentration in the presence of citrate will change serum magnesium concentrations.
Study Start Date: Jan. 28, 2025
Study Type: INTERVENTIONAL
Condition:
Dialysis; Complications
Interventi...